Protalix BioTherapeutics (PLX) Prepaid Assets (2014 - 2026)

Protalix BioTherapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Prepaid Assets fell 27.74% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 27.74% YoY), while the FY2025 annual figure was $1.1 million, up 125.8% from the prior year.
• Prepaid Assets was $1.1 million for Q1 2026 at Protalix BioTherapeutics, up from $1.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q2 2022 to a low of $444000.0 in Q4 2023.
• Historically, Prepaid Assets has averaged $1.3 million across 5 years, with a median of $1.1 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Prepaid Assets plunged 66.11% in 2023, then soared 125.8% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $1.3 million in 2022, then slumped by 66.11% to $444000.0 in 2023, then climbed by 12.61% to $500000.0 in 2024, then jumped by 125.8% to $1.1 million in 2025, then climbed by 1.77% to $1.1 million in 2026.
• The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.